Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jan 2;16(1):2.
doi: 10.1186/s13195-023-01367-7.

Digital Clock and Recall is superior to the Mini-Mental State Examination for the detection of mild cognitive impairment and mild dementia

Affiliations
Review

Digital Clock and Recall is superior to the Mini-Mental State Examination for the detection of mild cognitive impairment and mild dementia

Ali Jannati et al. Alzheimers Res Ther. .

Abstract

Background: Disease-modifying treatments for Alzheimer's disease highlight the need for early detection of cognitive decline. However, at present, most primary care providers do not perform routine cognitive testing, in part due to a lack of access to practical cognitive assessments, as well as time and resources to administer and interpret the tests. Brief and sensitive digital cognitive assessments, such as the Digital Clock and Recall (DCR™), have the potential to address this need. Here, we examine the advantages of DCR over the Mini-Mental State Examination (MMSE) in detecting mild cognitive impairment (MCI) and mild dementia.

Methods: We studied 706 participants from the multisite Bio-Hermes study (age mean ± SD = 71.5 ± 6.7; 58.9% female; years of education mean ± SD = 15.4 ± 2.7; primary language English), classified as cognitively unimpaired (CU; n = 360), mild cognitive impairment (MCI; n = 234), or probable mild Alzheimer's dementia (pAD; n = 111) based on a review of medical history with selected cognitive and imaging tests. We evaluated cognitive classifications (MCI and early dementia) based on the DCR and the MMSE against cohorts based on the results of the Rey Auditory Verbal Learning Test (RAVLT), the Trail Making Test-Part B (TMT-B), and the Functional Activities Questionnaire (FAQ). We also compared the influence of demographic variables such as race (White vs. Non-White), ethnicity (Hispanic vs. Non-Hispanic), and level of education (≥ 15 years vs. < 15 years) on the DCR and MMSE scores.

Results: The DCR was superior on average to the MMSE in classifying mild cognitive impairment and early dementia, AUC = 0.70 for the DCR vs. 0.63 for the MMSE. DCR administration was also significantly faster (completed in less than 3 min regardless of cognitive status and age). Among 104 individuals who were labeled as "cognitively unimpaired" by the MMSE (score ≥ 28) but actually had verbal memory impairment as confirmed by the RAVLT, the DCR identified 84 (80.7%) as impaired. Moreover, the DCR score was significantly less biased by ethnicity than the MMSE, with no significant difference in the DCR score between Hispanic and non-Hispanic individuals.

Conclusions: DCR outperforms the MMSE in detecting and classifying cognitive impairment-in a fraction of the time-while being not influenced by a patient's ethnicity. The results support the utility of DCR as a sensitive and efficient cognitive assessment in primary care settings.

Trial registration: ClinicalTrials.gov identifier NCT04733989.

Keywords: Alzheimer’s disease; Clock Drawing Test; Cognitive screening; Dementia; Digital cognitive assessment; Mild cognitive impairment; Mild neurocognitive disorder; Mini-Mental State Examination; Neurocognitive disorder; Rey Auditory Verbal Learning Test.

PubMed Disclaimer

Conflict of interest statement

APL is a co-founder and Chief Medical Officer of Linus Health and a co-founder of TI Solutions and declares ownership of shares or share options in the company. APL serves as a paid member of the scientific advisory boards for Neuroelectrics, Magstim Inc., TetraNeuron, Skin2Neuron, MedRhythms, and Hearts Radiant. DB is a co-founder and Chief Executive Officer of Linus Health and declares ownership of shares or share options in the company. JS is Chief Product Officer of Linus Health and declares ownership of shares or share options in the company. All other authors are employees of Linus Health and declare ownership of shares or share options in the company.

Figures

Fig. 1
Fig. 1
Scoring of the DCR (A), DCTclock (B), and Delayed Recall (C)
Fig. 2
Fig. 2
Cohort classification scheme based on the FAQ, RAVLT, and TMT-B scores. Starting with evaluating functional impairment (i.e., FAQ score ≥ 6), the decision tree considered verbal-memory (RAVLT) and executive (TMT) impairment. Impairment was defined as at least 1 standard deviation away from the age-adjusted mean in the direction of worse performance (e.g., slower TMT)
Fig. 3
Fig. 3
A AUCs for 200 iterations of the binary mild cognitive impairment (MCI) and mild/early dementia classification models. On each iteration, we randomly split the data into train/test sets using the same distribution matching and upsampling procedure. For each split, we then fitted the DCR and MMSE models as before and stored the resulting AUC. On average, the AUC for the DCR-based model (median = 0.70, SD = 0.03) was significantly greater than that for the MMSE (median = 0.63, SD = 0.02; paired permutation p < 0.0001) and was as good as the model inclusing all the sources of information (median = 0.7, SD = 0.032) including the DCR, the MMSE, and demographics. The dashed line represents 50% (chance level) classification accuracy. B The DCR took significantly less time to administer regardless of cohort (log-normal regression, p < 0.0001) and was less variable (DCR SD = 0.53; MMSE SD = 2.43)
Fig. 4
Fig. 4
Threshold-based classification of RAVLT-confirmed verbal memory impairment shows that the DCR commits substantially fewer misclassifications than the MMSE (light gray) and rescues more of the misclassifications done by the MMSE than vice versa (dark gray). Memory impairment was defined as delayed recall performance on RAVLT at or more than 1 SD below the age-normed mean. Impairment on the DCR was defined as a score of 3 or below, whereas impairment on the MMSE was defined as a score below 28
Fig. 5
Fig. 5
Influence of ethnicity, education, and race on DCR and MMSE scores. DCR scores were not significantly different between Hispanics and Non-Hispanics. A bootstrapping procedure showed that the bias (i.e., differences between groups per demographic) was always lower for the DCR

Similar articles

Cited by

References

    1. World Health Organization. WHO Disability and Health Fact Sheet. Cited 2023 Apr 10. Available from: https://apps.who.int/iris/rest/bitstreams/1343030/retrieve.
    1. Nichols E, Steinmetz JD, Vollset SE, Fukutaki K, Chalek J, Abd-Allah F, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7(2):e105–e125. doi: 10.1016/S2468-2667(21)00249-8. - DOI - PMC - PubMed
    1. Gaugler J, Bryan James TJ, Reimer J, Weuve J. Alzheimer’s Disease Facts and Figures, 17. Alzheimer’s Dementia: Chicago, IL; 2021.
    1. Eisai Inc. A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month Study With an Open-Label Extension Phase to Confirm Safety and Efficacy of BAN2401 in Subjects With Early Alzheimer’s Disease. clinicaltrials.gov; 2022 . Cited 2023 May 16. Report No.: NCT03887455. Available from: https://clinicaltrials.gov/ct2/show/NCT03887455.
    1. A Study of Donanemab (LY3002813) in Participants With Early Alzheimer’s Disease (TRAILBLAZER-ALZ 2) - Full Text View - ClinicalTrials.gov. Cited 2023 May 17. Available from: https://www.clinicaltrials.gov/ct2/show/NCT04437511.

Publication types

Associated data